Charles River Laboratories

At Charles River, we are incredibly proud of our work in #cancerresearch. We worked on 87% of all oncology drugs approved by the U.S. FDA in 2023. Throughout the month of September we will be sharing the impact of our work during #Oncology Awareness Month.

Digital #pathology is key to putting your #drugdevelopment program in the fast lane in your race from research to market. Explore how #pathologists can do more in less time, leveraging the latest in digitization and AI-support to streamline workflows and gain deeper insights, enabling you to bring better treatments to patients faster. https://okt.to/jTkL57

Screening your #chemical compound doesn’t have to be costly and time consuming. Ames and #micronucleus screening provide a rapid turnaround time at low costs while predicting risks in your compound. Watch the full webinar to gain insights on how predictive screening identifies your compound’s red flags early. https://okt.to/J1vRoZ

Modelling myelination in vitro is difficult due to the complexities of isolating and culturing primary oligodendrocyte. In this poster to be presented at #Neuroscience 2024, our scientists will outline an iPSC-derived model of myelination, with co-culture of oligodendrocytes and neurons, for use in multiple sclerosis drug discovery. https://okt.to/P0I7mV #SfN24 #multiplesclerosis #drugdiscovery

Discover how Priority Review Vouchers can significantly impact healthcare by accelerating access to life-saving treatments. An important US government program is on the chopping block September 30. Learn more at https://okt.to/FYqzKM

The local chapter of our Emotional Health & Wellness ERG in #Charleston, South Carolina collected three boxes worth of various school supplies items that they donated to a local school: W.B. Goodwin Elementary! Kelsey T. commented, "It was extremely uplifting and such a good feeling to see their reactions to our donations." Way to go team! #LIFEatCRL

Reflecting on #BIO2024, one of the highlights was the collaboration that went on during our visual map activity! Thank you all for contributing your insights and challenges on building momentum in the drug development journey and helping us create our unique visual map. If you missed our visual map activity or want to view the full visual map with key takeaways, check it out here: https://okt.to/q7rTUn

Are you ready to hit the ground running in a new #career? This is your moment. #careerdevelopment #jobopportunity

How researchers are using structural information and in silico modelling applications to improve the accuracy of #bifunctional protein degraders. Learn more about this on our Eureka Blog: https://okt.to/Qn69G1

“To build a purpose-built facility that reduces timelines, utilizing data to drive decisions.” Our Kansas facility was built with accelerating your program in mind, while also reducing how we work with animals in research in support of the 3R principles. https://okt.to/eDm3qy